New and promising GSM treatments, more clinical takeaways from NAMS 2018

Article Type
Changed
Thu, 12/15/2022 - 17:46
Display Headline
New and promising GSM treatments, more clinical takeaways from NAMS 2018

Learn more about NAMS: http://www.menopause.org/home

Author and Disclosure Information

Dr. Richard-Davis is Professor, Obstetrics and Gynecology, and Division Director, Reproductive Endocrinology and Infertility at the University of Arkansas for Medical Sciences, Little Rock, Arkansas.

The author reports no financial relationships related to this audio.

Issue
OBG Management - 30(10)
Publications
Topics
Sections
Author and Disclosure Information

Dr. Richard-Davis is Professor, Obstetrics and Gynecology, and Division Director, Reproductive Endocrinology and Infertility at the University of Arkansas for Medical Sciences, Little Rock, Arkansas.

The author reports no financial relationships related to this audio.

Author and Disclosure Information

Dr. Richard-Davis is Professor, Obstetrics and Gynecology, and Division Director, Reproductive Endocrinology and Infertility at the University of Arkansas for Medical Sciences, Little Rock, Arkansas.

The author reports no financial relationships related to this audio.

Learn more about NAMS: http://www.menopause.org/home

Learn more about NAMS: http://www.menopause.org/home

Issue
OBG Management - 30(10)
Issue
OBG Management - 30(10)
Publications
Publications
Topics
Article Type
Display Headline
New and promising GSM treatments, more clinical takeaways from NAMS 2018
Display Headline
New and promising GSM treatments, more clinical takeaways from NAMS 2018
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Tue, 10/16/2018 - 12:00
Un-Gate On Date
Tue, 10/16/2018 - 12:00
Use ProPublica
CFC Schedule Remove Status
Tue, 10/16/2018 - 12:00